<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Atypical_Hemolytic_Uremic_Syndrome_Initial_Continuation_Criteria_Q5</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>b) The only evidence of organ dysfunction is the kidney, and the eGFR has declined by &gt;25% after 6 months of eculizumab therapy</questionText>
        <responseValues>Present
Absent</responseValues>
        <status>Active</status>
        <versionNumber>2</versionNumber>
    </assessmentQuestionVersion>
    <dataType>Radio</dataType>
    <developerName>AHUS_Initial_Continuation_Criteria_Q5</developerName>
    <name>AHUS_Initial_Continuation_Criteria_Q5</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
